| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 10/14/1993 | WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression |
| 09/22/1993 | EP0561237A2 Enantiomer, (-)-N-(2-ethoxyphenyl)-N'-(1,2,2-trimethylpropyl)-2-nitromethene-1,1-diamine, process for its preparation and its use |
| 09/22/1993 | CN1022187C Method for preparation of tricyclic compounds |
| 09/21/1993 | CA1322372C Tetrahydrobenzothiazoles, and the preparation and use thereof |
| 09/21/1993 | CA1322328C Stabilized compositions containing epidermal growth factor |
| 09/19/1993 | CA2091634A1 Enantiomer (-)-n-(2-ethoxyphenyl)-n'- (1,2,2-trimethylpropyl)-2-nitroethene-1-, 1-diamine, process for the preparation thereof and the use thereof |
| 09/16/1993 | WO1993018034A1 Process for the preparation of ergoline derivatives |
| 09/16/1993 | WO1993017684A2 Enantiomeric hydroxylated xanthine compounds |
| 09/15/1993 | EP0559751A1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth). |
| 09/15/1993 | CN1076196A Process for the synthesis of ergoline derivatives |
| 09/14/1993 | US5244889 Treatment of cardiovascular disorders |
| 09/14/1993 | US5244886 11β-phenyl-14βH steroids |
| 09/08/1993 | EP0559240A2 Hormone composition containing estrogen and mogestin |
| 09/07/1993 | US5242951 Estrogen-containing gel preparation |
| 09/02/1993 | WO1993017014A1 Indole derivatives as steroid 5 alpha-reductase inhibitors |
| 09/01/1993 | EP0558416A1 New 17-(methylene)-lactone spiro condensed steroids, method and intermediates for their production, their use as medicines and pharmaceutical compositions containing them |
| 09/01/1993 | EP0434675B1 Polypeptide compounds having growth hormone releasing activity |
| 09/01/1993 | CN1075722A Steroid, preparing processing, intermediate and application |
| 08/24/1993 | US5238923 Amino-substituted heterocycles as renin inhibitors |
| 08/17/1993 | US5237110 19-nor-vitamin d compounds |
| 08/17/1993 | US5236906 Adrenocortical hormone and hyaluronic acid; skin diseases |
| 08/10/1993 | CA1321282C Parathyroid hormone antagonists |
| 08/10/1993 | CA1321281C Humoral hypercalcemic factor antagonists |
| 08/04/1993 | EP0355095B1 Pharmacological agent-lipid solution preparation |
| 08/03/1993 | US5232915 9α-hydroxy-19,11β-bridged steroids, their production and pharmaceutical preparations containing these steroids |
| 07/31/1993 | CA2087504A1 Administration of low dose hemoglobin to increase perfusion |
| 07/20/1993 | US5229403 Enzyme inhibitors, antiinflammatory |
| 07/13/1993 | US5227393 α-fluoro-α-tetrazolyl-phenylmethyl derivatives useful as aromatase inhibitors |
| 07/08/1993 | WO1993013123A1 Novel 19-nor steroids having a thiocarbon-containing chain in the 11beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositions containing said steroids |
| 07/08/1993 | WO1993012811A1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine |
| 07/08/1993 | CA2125856A1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine |
| 07/07/1993 | EP0550108A1 Sustained release thyroactive composition |
| 06/30/1993 | EP0549041A1 17-Spirofuran-3'-ylidene steroids |
| 06/30/1993 | EP0548824A1 Novel tricyclic steroid analogs |
| 06/30/1993 | CN1073684A Polypeptide analogues having growth hormone releasing activity |
| 06/30/1993 | CN1021445C Process for preparation of steroids including a spiro ring in position 17 |
| 06/30/1993 | CN1021444C Process for preparation of 16, 17-acetalsubstituted androstane-17 beta-carboxylic acid esters |
| 06/24/1993 | WO1993012083A1 22-oxacholecalciferol derivative and production thereof |
| 06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 06/21/1993 | CA2085819A1 Novel tricyclic steroid analogs |
| 06/16/1993 | EP0546449A2 Benzofuranderivatives as angiotensin II antagonists |
| 06/16/1993 | CN1073174A Heterocyclic derivatives |
| 06/15/1993 | US5219863 Angiotensin ii antagonizing compounds containing a 1,5-naphthyridine or a quinoline moiety |
| 06/15/1993 | CA1319148C Thyronine analogous compounds |
| 06/10/1993 | WO1993010741A2 Sex steroid activity inhibitors |
| 06/10/1993 | CA2084736A1 Benzofuranes |
| 06/08/1993 | US5217976 Hypotensive agents, congestive heart failure |
| 06/05/1993 | CA2082668A1 Heterocyclic derivatives |
| 06/02/1993 | EP0544620A1 Macrocyclic lactams as inhibitors of atrial natriuretic factors (ANF)-degrading neutral endopeptidase (NEP) |
| 06/01/1993 | US5215967 Aminoacid derivatives inhibiting renin |
| 05/27/1993 | WO1993010113A1 Novel benzothiophene derivative |
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 05/27/1993 | WO1993009785A1 Risedronate delayed-release compositions |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2083622A1 Certain macrocyclic lactam derivatives |
| 05/26/1993 | CN1020903C (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives and the preparation therefor |
| 05/25/1993 | CA1318463C Polypeptide compounds having growth hormone releasing activity |
| 05/19/1993 | EP0541822A1 Novel calcitonin, and production and use thereof |
| 05/18/1993 | US5212166 Antiandrogens or 5-alpha reductase inhibitors |
| 05/13/1993 | WO1993009222A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 05/13/1993 | WO1993009075A1 Method for separating enantiomers of aryloxipropanolamine derivatives, and chiral solid-phase chromatography material for use in the method |
| 05/13/1993 | CA2122991A1 Transfection of vertebrate cells by homologous recombination |
| 05/12/1993 | CN1071919A Benzanilide derivatives |
| 05/04/1993 | US5208263 Anti-androgen compounds |
| 05/04/1993 | CA1317225C Use of adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery |
| 04/28/1993 | EP0538942A2 Peptides representing permutations of the mastoparan sequence |
| 04/28/1993 | CN1071333A Calcium receptor active molecules |
| 04/27/1993 | US5206415 Modulation of gamma-aminobutyric acid receptor channel function |
| 04/13/1993 | US5202314 10-thioethyl-steroids |
| 04/06/1993 | US5200428 Enzyme inhibitors |
| 03/31/1993 | EP0534396A2 2-Substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/31/1993 | CN1070344A Composition for sustained and controlled release of medicamentous substances and process for preparing same |
| 03/24/1993 | EP0533268A1 Benzanilide derivatives as 5-HT1D antagonists |
| 03/24/1993 | EP0211894B1 Fsh |
| 03/19/1993 | CA2078505A1 Benzanilide derivatives |
| 03/18/1993 | WO1993005064A1 Steroid sulphatase inhibitors |
| 03/18/1993 | CA2305767A1 Steroid sulphatase inhibitors |
| 03/18/1993 | CA2305758A1 Steroid sulphatase inhibitors |
| 03/18/1993 | CA2305749A1 Steroid sulphatase inhibitors |
| 03/17/1993 | EP0531461A1 Biologically active peptides containing d-2-alkyltryptophan. |
| 03/17/1993 | EP0266426B1 Pseudouridine derivative |
| 03/16/1993 | US5194605 Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs |
| 03/16/1993 | CA1314656C Analogs of gonadoliberin with improved solubility, methods for their preparation, agents containing them and their use |
| 03/16/1993 | CA1314541C 17.beta.-n-monosubstituted carbamoyl -4-aza-5.- androst-1-en-3-ones |
| 03/04/1993 | WO1993004373A1 Calcium receptor active molecules |
| 03/04/1993 | WO1993003713A1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 03/03/1993 | CN1019978C 11-aryioestrane and 11-arylpregnalle derivatives and preparing method thereof |
| 02/24/1993 | EP0527914A1 Novel synthetic grf analogs |
| 02/18/1993 | WO1993003018A1 Compounds having angiotensine ii antagonistic activity |
| 02/18/1993 | CA2114621A1 Compounds having angiotensine ii antagonistic activity |
| 02/16/1993 | CA1313622C Pharmaceutical composition containing 17.beta.oestradiol and desogestr el |
| 02/10/1993 | EP0526658A1 Thiazolidine-2,4-dione derivative, salt thereof, and production of the same |
| 02/04/1993 | WO1993001802A1 Composition for the sustained and controlled release of a medicinal peptide-containing substance, and preparation method therefor |
| 02/02/1993 | US5183814 Selective oestrogen therapy for perimenopausal or postmenopausal conditions |
| 01/28/1993 | DE4223282A1 Zubereitung zur stetigen und kontrollierten abgabe von medikamentoesen substanzen und verfahren zu deren herstellung Preparation for continuous and controlled release of medicamentous substances and processes for their preparation |
| 01/26/1993 | US5182257 Anticarcinogenic agents |
| 01/12/1993 | CA1312704C Grf analogs vii |
| 01/07/1993 | EP0521586A1 FSH and other recombinant hormones |
| 12/30/1992 | EP0520427A1 Cyclopropenone derivatives |
| 12/22/1992 | CA1311749C 17.alpha.-(ARYLOXY OR ALKOXY) ANDROSTENES |